Price/FCF Ratio: 26.16
Is the Price/FCF ratio high or low?
The Price/FCF ratio of 26.16 is 14% below its 5-year average of 30.44, around the middle of its 5-year range (12.34–54.40).
10.77% below its 12-month average of 29.32.
NRC Price/FCF Ratio Chart
NRC Average Price/FCF Ratio Chart
NRC Current vs Average Price/FCF Ratio Chart
NRC Price/FCF Ratio Metrics
PRICE/FCF RATIO
26.16
PRICE/FCF RATIO AVG TTM
29.32
PRICE/FCF RATIO AVG 3Y
30.82
PRICE/FCF RATIO AVG 5Y
30.44
PRICE/FCF RATIO AVG 10Y
32.44
PRICE/FCF RATIO AVG 15Y
N/A
PRICE/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-10.77%
CURRENT VS 3Y AVG
-15.11%
CURRENT VS 5Y AVG
-14.06%
CURRENT VS 10Y AVG
-19.36%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
NRC Competitors' Price/FCF Ratio
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| National Research Corporation (NRC) | $468.99M | 26.16 | 29.32 | 30.82 | 30.44 |
| Shoulder Innovations, Inc. (SI)vs › | $472.62M | N/A | N/A | N/A | N/A |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.51B | 5.99 | 5.77 | 7.88 | 14.35 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | 21.16 | 22.19 | 21.55 | 20.25 |
| TransMedics Group, Inc. (TMDX)vs › | $2.37B | 16.37 | 102.71 | 102.71 | 102.71 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.56B | 98.49 | 78.94 | 71.21 | 71.21 |
| Oscar Health, Inc. (OSCR)vs › | $7.72B | 3.51 | 4.24 | 6.94 | 8.52 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.13B | 22.70 | 22.39 | 38.45 | 47.46 |
| Universal Health Services, Inc. (UHS)vs › | $9.12B | 10.06 | 13.59 | 19.00 | 41.62 |
Free Cash Flow Valuation
P/FCF Ratio
26.2
FCF Yield
3.82%
Price/FCF Ratio Formula & Definition
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Price/FCF Ratio FAQ
- What is the Price/FCF ratio for National Research Corporation (NRC)?
- The Price/FCF ratio for NRC stock is 26.16.
- Is National Research Corporation's Price/FCF ratio high or low?
- The Price/FCF ratio of 26.16 is 14% below its 5-year average of 30.44, around the middle of its 5-year range (12.34–54.40).
- What is the TTM average Price/FCF ratio for National Research Corporation (NRC)?
- The TTM average Price/FCF ratio for NRC stock is 29.32.
- What is the 3Y average Price/FCF ratio for National Research Corporation (NRC)?
- The 3Y average Price/FCF ratio for NRC stock is 30.82.
- What is the 5Y average Price/FCF ratio for National Research Corporation (NRC)?
- The 5Y average Price/FCF ratio for NRC stock is 30.44.
- What is the 10Y average Price/FCF ratio for National Research Corporation (NRC)?
- The 10Y average Price/FCF ratio for NRC stock is 32.44.
NRC Price/FCF Ratio History
| DATE | PRICE/FCF RATIO |
|---|---|
| 2026-06-26 | 26.16 |
| 2026-06-25 | 25.82 |
| 2026-06-24 | 26.02 |
| 2026-06-23 | 25.19 |
| 2026-06-22 | 24.50 |
| 2026-06-18 | 23.31 |
| 2026-06-17 | 22.31 |
| 2026-06-16 | 23.22 |
| 2026-06-15 | 23.02 |
| 2026-06-12 | 23.62 |
| 2026-06-11 | 23.62 |
| 2026-06-10 | 26.75 |
| 2026-06-09 | 24.83 |
| 2026-06-08 | 24.30 |
| 2026-06-05 | 24.06 |
| 2026-06-04 | 24.83 |
| 2026-06-03 | 23.93 |
| 2026-06-02 | 24.63 |
| 2026-06-01 | 25.46 |
| 2026-05-29 | 24.55 |
| 2026-05-28 | 24.71 |
| 2026-05-27 | 24.05 |
| 2026-05-26 | 23.93 |
| 2026-05-22 | 23.99 |
| 2026-05-21 | 23.93 |
| 2026-05-20 | 24.21 |
| 2026-05-19 | 23.57 |
| 2026-05-18 | 23.56 |
| 2026-05-15 | 23.41 |
| 2026-05-14 | 23.80 |
| 2026-05-13 | 23.47 |
| 2026-05-12 | 24.12 |
| 2026-05-11 | 23.52 |
| 2026-05-08 | 23.57 |
| 2026-05-07 | 23.55 |
| 2026-05-06 | 22.45 |
| 2026-05-05 | 25.96 |
| 2026-05-04 | 25.24 |
| 2026-05-01 | 24.11 |
| 2026-04-30 | 22.80 |
| 2026-04-29 | 22.91 |
| 2026-04-28 | 23.33 |
| 2026-04-27 | 23.70 |
| 2026-04-24 | 23.87 |
| 2026-04-23 | 23.89 |
| 2026-04-22 | 24.24 |
| 2026-04-21 | 23.80 |
| 2026-04-20 | 25.18 |
| 2026-04-17 | 24.97 |
| 2026-04-16 | 24.41 |
| 2026-04-15 | 24.71 |
| 2026-04-14 | 23.60 |
| 2026-04-13 | 23.30 |
| 2026-04-10 | 22.83 |
| 2026-04-09 | 23.62 |
| 2026-04-08 | 23.91 |
| 2026-04-07 | 23.60 |
| 2026-04-06 | 24.00 |
| 2026-04-02 | 23.77 |
| 2026-04-01 | 24.02 |
| 2026-03-31 | 23.52 |
| 2026-03-30 | 23.74 |
| 2026-03-27 | 23.73 |
| 2026-03-26 | 24.27 |
| 2026-03-25 | 23.80 |
| 2026-03-24 | 24.16 |
| 2026-03-23 | 24.25 |
| 2026-03-20 | 23.99 |
| 2026-03-19 | 23.98 |
| 2026-03-18 | 24.34 |
| 2026-03-17 | 24.56 |
| 2026-03-16 | 24.10 |
| 2026-03-13 | 22.88 |
| 2026-03-12 | 22.85 |
| 2026-03-11 | 22.18 |
| 2026-03-10 | 22.54 |
| 2026-03-09 | 20.73 |
| 2026-03-06 | 20.21 |
| 2026-03-05 | 19.45 |
| 2026-03-04 | 25.50 |
| 2026-03-03 | 26.03 |
| 2026-03-02 | 26.92 |
| 2026-02-27 | 26.07 |
| 2026-02-26 | 26.13 |
| 2026-02-25 | 25.13 |
| 2026-02-24 | 24.28 |
| 2026-02-23 | 24.30 |
| 2026-02-20 | 26.57 |
| 2026-02-19 | 24.20 |
| 2026-02-18 | 23.97 |
| 2026-02-17 | 23.39 |
| 2026-02-13 | 23.48 |
| 2026-02-12 | 24.94 |
| 2026-02-11 | 26.73 |
| 2026-02-10 | 28.30 |
| 2026-02-09 | 29.88 |
| 2026-02-06 | 30.99 |
| 2026-02-05 | 30.97 |
| 2026-02-04 | 29.68 |
| 2026-02-03 | 34.25 |
| 2026-02-02 | 42.57 |
| 2026-01-30 | 39.54 |
| 2026-01-29 | 38.98 |
| 2026-01-28 | 38.51 |
| 2026-01-27 | 39.56 |
| 2026-01-26 | 40.45 |
| 2026-01-23 | 40.96 |
| 2026-01-22 | 42.79 |
| 2026-01-21 | 43.70 |
| 2026-01-20 | 42.55 |
| 2026-01-16 | 43.19 |
| 2026-01-15 | 41.40 |
| 2026-01-14 | 40.51 |
| 2026-01-13 | 40.59 |
| 2026-01-12 | 39.71 |
| 2026-01-09 | 38.33 |
| 2026-01-08 | 37.89 |
| 2026-01-07 | 36.74 |
| 2026-01-06 | 37.52 |
| 2026-01-05 | 36.55 |
| 2026-01-02 | 35.05 |
| 2025-12-31 | 36.49 |
| 2025-12-30 | 36.25 |
| 2025-12-29 | 36.88 |
| 2025-12-26 | 36.27 |
| 2025-12-24 | 36.56 |
| 2025-12-23 | 36.95 |
| 2025-12-22 | 36.70 |
| 2025-12-19 | 36.35 |
| 2025-12-18 | 37.52 |
| 2025-12-17 | 36.23 |
| 2025-12-16 | 35.83 |
| 2025-12-15 | 34.99 |
| 2025-12-12 | 34.29 |
| 2025-12-11 | 33.86 |
| 2025-12-10 | 32.91 |
| 2025-12-09 | 31.18 |
| 2025-12-08 | 30.81 |
| 2025-12-05 | 30.85 |
| 2025-12-04 | 31.72 |
| 2025-12-03 | 31.43 |
| 2025-12-02 | 31.49 |
| 2025-12-01 | 32.64 |
| 2025-11-28 | 33.03 |
| 2025-11-26 | 33.57 |
| 2025-11-25 | 35.03 |
| 2025-11-24 | 33.67 |
| 2025-11-21 | 34.33 |
| 2025-11-20 | 32.29 |
| 2025-11-19 | 31.70 |
| 2025-11-18 | 31.20 |
| 2025-11-17 | 31.14 |
| 2025-11-14 | 29.61 |
| 2025-11-13 | 30.21 |
| 2025-11-12 | 29.99 |
| 2025-11-11 | 29.02 |
| 2025-11-10 | 28.15 |
| 2025-11-07 | 28.58 |
| 2025-11-06 | 35.04 |
| 2025-11-05 | 34.38 |
| 2025-11-04 | 33.67 |
| 2025-11-03 | 32.38 |
| 2025-10-31 | 32.65 |
| 2025-10-30 | 32.01 |
| 2025-10-29 | 32.87 |
| 2025-10-28 | 32.38 |
| 2025-10-27 | 27.91 |
| 2025-10-24 | 28.49 |
| 2025-10-23 | 28.49 |
| 2025-10-22 | 29.08 |
| 2025-10-21 | 29.54 |
| 2025-10-20 | 29.15 |
| 2025-10-17 | 28.37 |
| 2025-10-16 | 28.54 |
| 2025-10-15 | 27.98 |
| 2025-10-14 | 28.15 |
| 2025-10-13 | 28.05 |
| 2025-10-10 | 28.05 |
| 2025-10-09 | 28.64 |
| 2025-10-08 | 29.13 |
| 2025-10-07 | 29.37 |
| 2025-10-06 | 29.50 |
| 2025-10-03 | 29.84 |
| 2025-10-02 | 30.45 |
| 2025-10-01 | 30.55 |
| 2025-09-30 | 31.23 |
| 2025-09-29 | 31.21 |
| 2025-09-26 | 32.50 |
| 2025-09-25 | 33.85 |
| 2025-09-24 | 35.56 |
| 2025-09-23 | 35.85 |
| 2025-09-22 | 37.19 |
| 2025-09-19 | 36.17 |
| 2025-09-18 | 38.83 |
| 2025-09-17 | 38.88 |
| 2025-09-16 | 39.25 |
| 2025-09-15 | 39.59 |
| 2025-09-12 | 39.12 |
| 2025-09-11 | 39.59 |
| 2025-09-10 | 38.83 |
| 2025-09-09 | 39.44 |
| 2025-09-08 | 38.49 |
| 2025-09-05 | 37.63 |
| 2025-09-04 | 36.56 |
| 2025-09-03 | 36.00 |
| 2025-09-02 | 36.83 |
| 2025-08-29 | 35.90 |
| 2025-08-28 | 35.80 |
| 2025-08-27 | 37.83 |
| 2025-08-26 | 37.58 |
| 2025-08-25 | 37.29 |
| 2025-08-22 | 37.56 |
| 2025-08-21 | 35.46 |
| 2025-08-20 | 38.41 |
| 2025-08-19 | 39.51 |
| 2025-08-18 | 37.90 |
| 2025-08-15 | 37.41 |
| 2025-08-14 | 36.66 |
| 2025-08-13 | 38.05 |
| 2025-08-12 | 37.95 |
| 2025-08-11 | 36.88 |
| 2025-08-08 | 36.90 |
| 2025-08-07 | 22.59 |
| 2025-08-06 | 21.78 |
| 2025-08-05 | 21.24 |
| 2025-08-04 | 21.01 |
| 2025-08-01 | 19.35 |
| 2025-07-31 | 19.22 |
| 2025-07-30 | 19.42 |
| 2025-07-29 | 20.39 |
| 2025-07-28 | 21.44 |
| 2025-07-25 | 21.36 |
| 2025-07-24 | 21.72 |
| 2025-07-23 | 22.65 |
| 2025-07-22 | 21.78 |
| 2025-07-21 | 21.61 |
| 2025-07-18 | 21.87 |
| 2025-07-17 | 22.99 |
| 2025-07-16 | 22.99 |
| 2025-07-15 | 23.22 |
| 2025-07-14 | 23.65 |
| 2025-07-11 | 24.55 |
| 2025-07-10 | 25.02 |
| 2025-07-09 | 25.75 |
| 2025-07-08 | 25.95 |
| 2025-07-07 | 25.33 |
| 2025-07-03 | 26.16 |
| 2025-07-02 | 25.44 |
| 2025-07-01 | 25.64 |
| 2025-06-30 | 25.84 |
| 2025-06-27 | 25.64 |
| 2025-06-26 | 24.90 |
| 2025-06-25 | 25.90 |
| 2025-06-24 | 26.51 |
| 2025-06-23 | 26.15 |
| 2025-06-20 | 25.45 |
| 2025-06-18 | 25.88 |
| 2025-06-17 | 25.79 |
| 2025-06-16 | 25.58 |
| 2025-06-13 | 24.67 |
Showing the most recent 260 of 3,293 data points. The chart above shows the full history.
Related Metrics
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green